Attendees heard from industry leaders during exclusive sessions with Dr. Fein.
DCLF 2025 Event Video
The gathering on the future of drug channels.
The gathering on the future of drug channels.
Drug Channels Leadership Forum
Candid. Consequential. The gathering on the future of drug channels.
Featuring candid conversations with top leaders, innovators, and policy makers on key topics shaping the U.S. pharmaceutical ecosystem.
The Drug Channels Leadership Forum returns for its second year to explore the most pressing strategic challenges and emerging uncertainties shaping the future of the U.S. drug channel. Join us for this exclusive opportunity to learn, share, and engage with a curated group of senior leaders and decision-makers from every corner of the drug channel ecosystem.
March 16–18, 2026
JW Marriott Miami Turnberry Resort and Spa
Miami, Florida
Featuring candid conversations with top leaders, innovators, and policy makers on key topics shaping the U.S. pharmaceutical ecosystem.
The Drug Channels Leadership Forum returns for its second year to explore the most pressing strategic challenges and emerging uncertainties shaping the future of the U.S. drug channel. Join us for this exclusive opportunity to learn, share, and engage with a curated group of senior leaders and decision-makers from every corner of the drug channel ecosystem.
March 16–18, 2026
JW Marriott Miami Turnberry Resort and Spa
Miami, Florida
Moderator
Adam J. Fein is President of Drug Channels Institute (DCI), an HMP Global company. DCI helps its customers make sense of pharmaceutical economics and the increasingly complex pharmacy distribution and reimbursement system.
Dr. Fein is one of the country’s foremost experts on the pharmaceutical industry. He has published hundreds of academic and industry articles. Dr. Fein has contributed to and is regularly quoted in such national publications as the Wall Street Journal, the New York Times, Washington Post, Forbes, and many others. His popular and influential Drug Channels website is the go-to source for definitive and comprehensive industry analysis, delivered with a witty edge.
2026 Fireside Chat Participants
-
Debbie WeitzmanCEO, Pharmaceutical & Specialty Solutions | Cardinal HealthDebbie Weitzman is the chief executive officer of the Pharmaceutical and... -
Mostafa KamalPresident and Chief Executive Officer | Prime TherapeuticsAs president and CEO of Prime Therapeutics, Mostafa Kamal leads Prime and... -
Kevin Host, PharmDSenior Vice President, Pharmacy | WalmartKevin Host is Senior Vice President of Pharmacy at Walmart, which includes... -
Jeff DavisExecutive Director, National Channel | AstraZenecaJeff leads the National Channel Account Team, as part of the US Market... -
Christine G. Marsh, MBASenior Vice President, Value & Access | Boehringer IngelheimChristine (Chris) Marsh, Senior Vice President, currently leads the Value &... -
Jennifer NortonSenior Vice President, Patient and Market Access | Takeda PharmaceuticalsJen Norton is the Senior Vice President of U.S. Patient and Market Access...
Fireside Chats
Delve into the heart of industry trends and challenges with intimate fireside chats with industry thought leaders, analysts, and executives at the drug channels forefront. Dr. Fein will personally lead those fireside discussions.
Salon-Style Format
Experience a dynamic and interactive environment where ideas flow freely and collaboration thrives. Our salon-style approach fosters open dialogue and a meaningful exchange of perspectives. Engage in lively discussions and debates on the most pressing issues facing pharmaceutical distribution channels.
Provocative Discussions
Engage in thought-provoking conversations that explore the complexities of the rapidly evolving drug channels landscape. Delve into disruption and what’s driving success today.
Real and Candid Conversation
Drug Channels Leadership Forum will tackle pressing topics and ask tough questions.
Networking
Connect and cultivate relationships with thought leaders and solution providers that extend beyond the forum, further driving collaboration and growth.
Back to top